CHICAGO, Jan 30 (Reuters) - The U.S. Food and Drug Administration warned pharmaceutical provider Omnicare Inc. (OCR.N: Quote, Profile , Research) that its plan to correct problems at a troubled packaging plant is incomplete and risks product contamination or mix-ups.
